At a Glance
Dosage
Only in Glycine
oral
| Level | Dose |
|---|---|
| Threshold | 600 mg |
| Light | 1000–2000 |
Dopamine, a Neurotransmitter, and Glycine, a Inhibitory neurotransmitter, NMDA co-agonist, Sleep aid, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Dopamine is classified as a Neurotransmitter while Glycine is a Inhibitory neurotransmitter, NMDA co-agonist, Sleep aid, meaning they approach altered states through different pharmacological mechanisms. They share 1 documented effects in common, with 9 effects unique to Dopamine and 1 unique to Glycine. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Common | 3000–5000 mg |
| Strong | 5000–10000 mg |
| Heavy | 15000 mg |
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.